Life Sciences 360
✓

Life Sciences 360
Listen Score
LS 26
Global Rank
TOP 10%

OM DENNE PODCAST 🔗

Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the show both informative and useful.

Videnskab
Biovidenskab
Værter:
Opdateringsfrekvens:
every 11 days
Gennemsnitlig lydlængde:
37 minutes
Gæsteinterviews
Engelsk
USA
86 episoder
siden 8. februar 2023
episodic
BrugAPItil at hente denne podcast iJSON

I DENNE PODCAST 🔗

Redigér disse tags

SENESTE EPISODE 🔗

Why Every Medical Affairs Team Needs Their Own AI Agent in 2025

Why Every Medical Affairs Team Needs Their Own AI Agent in 2025

Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator). Learn how AI in biotech is tackling the complexities of medical affairs—from literature re…
00:48:31
DEL
GEM

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Life Sciences 360.
Integrer denne søgefelt på dit websted

SIDSTE EPISODER

VC Money Tight? Here’s How Startups Still Land Top Talent (2025)

VC Money Tight? Here’s How Startups Still Land Top Talent (2025)

What happens when 3,500 staffers lose their jobs due to FDA layoffs, venture capital (VC) term sheets shrink, and AI drug-discovery startups raise $600 million rounds? Executive recruiter William Holodnak (ex-Fidelity, global biotech headhunter) breaks down 2025’s wild hiring market—and how founder…
00:46:37
DEL
GEM
Why Most Healthcare Brands Fail (And How to Fix It)

Why Most Healthcare Brands Fail (And How to Fix It)

· udskrift
Why Most Healthcare Brands Fail (And How to Fix It)In this episode, Holley Miller, Founder and President of Grey Matter Marketing, reveals why most medtech and life sciences companies fail to connect with their audience—and how to fix that with brand clarity and strategic storytelling.You’ll learn …
00:50:33
DEL
GEM
4.5 Billion Molecules, One Mission: Cure the ‘Undruggable’ Diseases

4.5 Billion Molecules, One Mission: Cure the ‘Undruggable’ Diseases

· udskrift
Solving the “Undruggable” Disease Problem with Goldilocks MoleculesIn this episode, Christian Schafmeister, Founder and President of Third Law Molecular, reveals a new class of therapeutics designed to target what most consider “undruggable” diseases—conditions like Alzheimer’s, certain cancers, an…
00:30:57
DEL
GEM
What Separates Life Science Startup Winners from Losers?

What Separates Life Science Startup Winners from Losers?

· udskrift
Why Startups Fail (Hint: It’s Not the Innovation)In this episode, Carlo Odicino, CEO and Founder at One TEAM Partners, shares the real reasons why most early-stage life sciences companies struggle to survive—and it has nothing to do with bad science.Learn the hidden pitfalls of scaling too fast, co…
00:38:46
DEL
GEM
Pandora's Box of Secrets EXPOSED in Drug Pricing Transparency!

Pandora's Box of Secrets EXPOSED in Drug Pricing Transparency!

· udskrift
The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They ShouldIn this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug pricing ecosystem—revealing how rebates, PBMs, and outdated pricing models shape what patients actually pay.You’ll learn ho…
00:30:15
DEL
GEM
A CCO’s Brutally Honest Advice if You Want to Succeed in Pharma Commercialization

A CCO’s Brutally Honest Advice if You Want to Succeed in Pharma Commercialization

· udskrift
Early Commercialization Strategies That Actually Work (Especially for Startups!) In this episode, John Harlow, Chief Commercial Officer at Melinta Therapeutics, shares real-world strategies for how lean pharma startups can win the commercialization game—without Big Pharma budgets.Discover how small…
00:31:45
DEL
GEM
Digital Health Expert: THIS is the No.1 Roadblock to Healthcare AI Adoption

Digital Health Expert: THIS is the No.1 Roadblock to Healthcare AI Adoption

· udskrift
Healthcare AI adoption is transforming the way we address risk, confidentiality, and patient care. In this episode, RJ Kedziora, co-founder of Estenda Solutions talks about the practical steps to safely integrate AI in clinical workflows. Learn how to manage data privacy, mitigate algorithmic bias,…
00:35:12
DEL
GEM
Tired of Supply Chain Errors? Here’s the Fix: Drug Serialization for DSCSA Compliance

Tired of Supply Chain Errors? Here’s the Fix: Drug Serialization for DSCSA Compliance

· udskrift
Drug serialization is at the heart of modern pharmaceutical supply chain security. In this episode  Michael Rowe, Senior Director of DSCSA and Serialization Services at TwoLabs, talks about the critical role of drug serialization and DSCSA compliance in safeguarding the pharmaceutical supply chain.…
00:39:50
DEL
GEM
Why Equitable Healthcare is the KEY to Better Health

Why Equitable Healthcare is the KEY to Better Health

· udskrift
Equitable healthcare is the key to bridging health gaps and creating better patient outcomes. In this episode, Amy West, Principal, Advisory Services at HitLab, share her insights on how technology, digital health, and data can reshape access to care—especially for underserved communities. Learn ho…
00:22:03
DEL
GEM
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Harsh Thakkar, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
PODCAST SØGEMOTOR
Du kan bruge vores hjemmeside til at søge efter3,829,318podcasts og196,592,684episoder efter personer, steder eller emner.
En investering i viden giver det bedste afkast, så jeg lytter til podcasts.  ‐ Benjamin "Llamacorn" Franklin

ANBEFALINGER

Brug API til at hente denne podcast